Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;144(4):601-6.
doi: 10.1309/AJCPQV4A7QAEEFEV.

The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis

Michele M Tana  1 , Zakera Shums  2 , Jay Milo  2 , Gary L Norman  2 , Patrick S Leung  3 , M Eric Gershwin  3 , Mazen Noureddin  4 , David E Kleiner  4 , Xiongce Zhao  4 , Theo Heller  4 , Jay H Hoofnagle  4
Affiliations

The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis

Michele M Tana et al. Am J Clin Pathol. 2015 Oct.

Abstract

Objectives: In primary biliary cirrhosis (PBC), the antimitochondrial antibody is a cornerstone of diagnosis, but there have been conflicting reports about the correlation of autoantibodies with disease stage and prognosis. We studied whether autoantibody levels changed over time and sought correlations with clinical outcomes in a cohort of patients with PBC.

Methods: We tested serial serum samples from patients with PBC at a research institution for several autoantibodies. Long-term clinical follow-up data were used to calculate the slopes (change over time) for autoantibodies, platelet count, Ishak fibrosis score, biopsy copper, and number of portal areas with bile ducts. An adverse clinical outcome was defined as hepatic decompensation, development of hepatocellular carcinoma, liver transplantation, or liver-related death. We performed linear or logistic regression or Fisher exact test as appropriate, adjusting for multiple comparisons.

Results: Twenty-seven patients with PBC with 145 serum samples were studied. Of the cohort, 85% was white, 81% was female, and median follow-up time was 20 years. Of the autoantibodies tested, only sp100 changed significantly over time. The sp100 slope was inversely associated with the Ishak fibrosis slope (parameter estimate, -0.05; P = .0003).

Conclusions: While changes in most autoantibodies over time do not seem to correlate with clinical outcomes in PBC, a change in the sp100 autoantibody level may have prognostic utility with respect to the development of fibrosis on liver biopsy.

Keywords: Autoantibodies; Autoimmune liver disease; Primary biliary cirrhosis; Prognosis; Serum markers; Ursodiol.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The sp100 slope is inversely associated with the Ishak fibrosis slope (P = .0003).
See this image and copyright information in PMC

References

    1. Walker JG, Doniach D, Roitt IM, et al. Serological tests in diagnosis of primary biliary cirrhosis. Lancet. 1965;1:827–831. - PubMed
    1. Lleo A, Invernizzi P, Mackay IR, et al. Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol. 2008;14:3328–3337. - PMC - PubMed
    1. Van de Water J, Cooper A, Surh CD, et al. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med. 1989;320:1377–1380. - PubMed
    1. Muratori P, Muratori L, Ferrari R, et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol. 2003;98:431–437. - PubMed
    1. Heseltine L, Turner IB, Fussey SP, et al. Primary biliary cirrhosis: quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. Gastroenterology. 1990;99:1786–1792. - PubMed

Publication types